| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db889de540f1640afc29772109da9a27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ee06fc836fcae3e47f2a68c86f4ee66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d974e21dbdc5fcbf493e8c5c09b8536 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2009-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564ac72710ad1b6a2be7c7e4ff08e381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d6d0725f34df78354f05b27a84648b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fe084977436fda13ab60a8ec061627a |
| publicationDate |
2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2385251-A1 |
| titleOfInvention |
ONCOLITICAL ADENOVIRUS FOR THE TREATMENT OF CANCER. |
| abstract |
Oncolytic adenovirus for the treatment of cancer. # The invention relates to an oncolytic adenovirus comprising a sequence encoding a hyaluronidase enzyme inserted into its genome. This adenovirus is distributed more efficiently by the tumor mass and therefore the oncolytic effect is increased. Injecting the oncolytic adenovirus of the invention intravenously, regressions of the tumor volume are obtained. Therefore the oncolytic adenovirus of the present invention is useful for the treatment of cancer or a pre-malignant state thereof. |
| priorityDate |
2009-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |